Assessing the Performance of Lotrafilcon A Lenses During a Three Month Period
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Lotrafilcon A contact lens
- Registration Number
- NCT00933166
- Lead Sponsor
- CIBA VISION
- Brief Summary
The purpose of this trial is to assess the performance of an investigational contact lens over a three month period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 169
Inclusion Criteria
- On examination, have ocular findings considered to be "normal," and which would not prevent a participant from safely wearing contact lenses.
- Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent.
- Be able to wear the study lenses in the available powers.
- Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria
- Eye injury or surgery within twelve weeks of enrollment.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in an ophthalmic clinical trial.
- Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
- History of corneal refractive surgery.
- Other protocol-defined inclusion/exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Lotrafilcon A Lotrafilcon A contact lens Investigational contact lens worn in both eyes for three months
- Primary Outcome Measures
Name Time Method Comfort After Insertion 3 months Comfort after insertion (30 seconds to 1 minute) as interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of three months' wear time. Comfort after insertion was measured on a 10-point scale, with 1 being poor and 10 being excellent.
- Secondary Outcome Measures
Name Time Method